NCT04301089: Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Anxiety